Stock Earnings

Question 1

What are Sinopharm Group Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Sinopharm Group Co Ltd has a total asset of $392,831, Net profit of $7,049

Question 2

What are the key financial ratios for SHTDY?

Accepted Answer

Sinopharm Group Co Ltd's Current ratio is 1.25, has a Net margin is 1.2, sales per share of $187.3.

Question 3

How is Sinopharm Group Co Ltd's revenue broken down by segment or geography?

Accepted Answer

Sinopharm Group Co Ltd largest revenue segment is Pharmaceutical Distribution, at a revenue of 460,322,005,211 in the most earnings release.For geography, China is the primary market for Sinopharm Group Co Ltd, at a revenue of 633,737,461,156.

Question 4

Is Sinopharm Group Co Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Sinopharm Group Co Ltd has a net profit of $7,049

Question 5

Does Sinopharm Group Co Ltd have any liabilities?

Accepted Answer

yes, Sinopharm Group Co Ltd has liability of 313,947

Question 6

How many outstanding shares for Sinopharm Group Co Ltd?

Accepted Answer

Sinopharm Group Co Ltd has a total outstanding shares of 3,120.65

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	575,824	584,507	596,569	552,147	521,051	456,414
Revenue Growth (YoY)	-2%	-2%	8%	6%	14%	7%
Cost of Revenue	533,165	540,252	548,057	504,713	477,000	416,091
Gross Profit	42,659	44,255	48,511	47,434	44,050	40,323
Selling, General & Admin	26,144	26,697	27,082	23,790	22,101	20,328
Research & Development	--	--	--	--	--	--
Operating Expenses	25,585	26,484	26,234	24,893	23,207	21,289
Other Non Operating Income (Expenses)	94	-165	-140	-131	-92	-286
Pretax Income	13,614	14,000	19,512	18,563	17,003	15,598
Income Tax Expense	3,752	3,577	4,502	4,218	3,938	3,500
Net Income	6,811	7,049	9,053	8,525	7,758	7,187
Net Income Growth	-21%	-22%	6%	10%	8%	15%
Shares Outstanding (Diluted)	3,120.53	3,120.65	3,120.65	3,120.65	3,120.65	3,111.29
Shares Change (YoY)	0%	0%	0%	0%	0%	5%
EPS (Diluted)	2.18	2.25	2.9	2.73	2.48	2.31
EPS Growth	-21%	-22%	6%	10%	8%	10%
Free Cash Flow	17,094	9,577	14,837	18,546	7,052	9,067
Free Cash Flow Per Share	5.47	3.06	4.75	5.94	2.25	2.91
Gross Margin	7.4%	7.57%	8.13%	8.59%	8.45%	8.83%
Operating Margin	2.96%	3.04%	3.73%	4.08%	3.99%	4.17%
Profit Margin	1.18%	1.2%	1.51%	1.54%	1.48%	1.57%
Free Cash Flow Margin	2.96%	1.63%	2.48%	3.35%	1.35%	1.98%
EBITDA	21,714	22,503	26,706	26,705	24,764	22,630
EBITDA Margin	3.77%	3.84%	4.47%	4.83%	4.75%	4.95%
D&A For EBITDA	4,641	4,733	4,430	4,165	3,922	3,597
EBIT	17,073	17,770	22,276	22,540	20,842	19,033
EBIT Margin	2.96%	3.04%	3.73%	4.08%	3.99%	4.17%
Effective Tax Rate	27.55%	25.55%	23.07%	22.72%	23.16%	22.43%

Sinopharm Group Co Ltd (SHTDY) Price

SHTDY Stock Price Chart

SHTDY Income

Follow-Up Questions